CanniMed CEO resigns as Aurora acquisition nears completion
The chief executive officer of CanniMed Therapeutics has resigned, effective immediately, as Aurora Cannabis wraps up its acquisition of the medical marijuana company.
April 3, 2018 By The Canadian Press
According to a statement issued by the companies, CEO Brent Zettl, who helped co-found the Saskatoon-based licensed producer in 1988, is pursuing other opportunities.
He has agreed to remain available to CanniMed and Aurora as they integrate the two companies.
Aurora’s senior vice-president of business integration Andre Jerome has been appointed as interim chief executive.
In January, Aurora struck a stock-and-cash deal valued at $1.1 billion to buy CanniMed.
The agreement ended a sometimes-terse takeover battle between the two marijuana companies.
Print this page